Human intelligence enhanced by artificial intelligence
A revolution in structural heart identification and management
How are you reducing heart failure readmissions?
How do you know if a structural heart patient has been missed?
How are you reducing heart failure readmissions?
How do you know if a structural heart patient has been missed?
Human intelligence enhanced by artificial intelligence
A revolution in structural heart identification and management
The Solution 
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
The Leading Structural Heart Platform Has Expanded into Heart Failure:
Aortic
Stenosis
Mitral
Stenosis
Tricuspid
Regurgitation
Heart
Failure
Aortic
Regurgitation
Mitral
Regurgitation
Aortic
Stenosis
Mitral
Stenosis
Tricuspid
Regurgitation
Heart
Failure
Aortic
Regurgitation
Mitral
Regurgitation
Aortic
Stenosis
Aortic
Regurgitation
Mitral
Stenosis
Mitral
Regurgitation
Tricuspid
Regurgitation
Heart
Failure
Overview
The CardioCare Platform
Providing a comprehensive view of structural heart patients, now helping heart programs identify their most at-risk patient populations. This leading-edge combination of artificial intelligence solutions and big data analytics help to close gaps that can cause undertreatment in structural heart disease.
Sites Observed Procedural Growth One Year After Implementing the CardioCare Platform:
Aortic Stenosis
Procedural Growth
+45%
Mitral Regurgitation
Procedural Growth
+54%
Tricuspid Regurgitation
Procedural Growth
+46%
**Analysis represents median growth from 8 CardioCare sites with baseline data one year after implementing the CardioCare program.
Now Introducing
Insights to Help Improve Outcomes for Your Heart Failure Patients
1Early data representing 5 heart programs managing more than 50,000 HFrEF patients. Heart failure with a reduced ejection fraction is defined as (HFrEF) and guideline-directed medical therapy (GDMT) is defined by patients being prescribed all 4 medications to treat heart failure. 2Observed in patients prescribed all 4 guideline-directed medications compared to those with 0 guideline-directed medications.
The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of structural heart diseases.
The Solution
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
How it Works
Artificial Intelligence Solutions to Close Gaps in Care
The CardioCare platform is the industry leader in structural heart insights, focused on reducing variability in care and improving guideline-directed treatment through:
Big
Data
Leveraging AI from millions of records to help you understand your hospitals entire structural heart patient population
Insights
On Demand
Prioritizing care for patients eligible for life saving treatment
Predictive Algorithms
Helping physicians identify patients with a higher likelihood of having undiagnosed severe disease
* The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of structural heart diseases.
Testimonials
Leading hospitals partner with egnite’s CardioCare program to reduce variability in diagnoses and improve guideline-directed therapy for patients with structural heart disease.
Swedish Medical Center
Director of Structural Interventions, Stanford Health Care
Vice President Northwestern Medical Group Chief, Division of Cardiac Surgery
Resources
Become a Best-in-Class Structural Heart Program
The CardioCare platform has partnered with healthcare systems extensively to help elevate the standard of structural heart patient care. Data uncovered from this experience have helped us understand what best-in-class patient care looks like nationwide.
The CardioCare Platform Addresses Real-World Challenges in Structural Heart Disease Patient Care
The CardioCare platform uses big data analytics and artificial intelligence powered technology to help physicians elevate the standard of patient care.
egnite Improves Care for Structural Heart Disease Patients
egnite is doing more than just re-imagining healthcare. As these three clinical cases show, egnite is applying digital technology and partnering with leading physicians to solve healthcare's most formidable challenges...